UNICA IRIS Institutional Research Information System

SCHERMA, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 119.948
NA - Nord America 8.195
AS - Asia 3.294
SA - Sud America 495
Continente sconosciuto - Info sul continente non disponibili 335
AF - Africa 107
OC - Oceania 9
Totale 132.383
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 118.111
US - Stati Uniti d'America 7.955
SG - Singapore 1.217
CN - Cina 1.064
SE - Svezia 462
BR - Brasile 390
VN - Vietnam 315
UA - Ucraina 294
DE - Germania 231
FI - Finlandia 206
GB - Regno Unito 200
FR - Francia 138
CA - Canada 122
IN - India 101
HK - Hong Kong 90
KR - Corea 77
BD - Bangladesh 73
NL - Olanda 73
TR - Turchia 65
AR - Argentina 45
ES - Italia 41
IQ - Iraq 39
RU - Federazione Russa 36
JP - Giappone 32
PL - Polonia 32
MX - Messico 31
PK - Pakistan 28
AT - Austria 22
SA - Arabia Saudita 22
ZA - Sudafrica 22
UZ - Uzbekistan 21
EC - Ecuador 20
MA - Marocco 20
PH - Filippine 17
IL - Israele 16
BE - Belgio 15
IE - Irlanda 14
JM - Giamaica 14
JO - Giordania 13
CZ - Repubblica Ceca 12
IR - Iran 12
NP - Nepal 12
CO - Colombia 11
AE - Emirati Arabi Uniti 10
CR - Costa Rica 10
ET - Etiopia 10
LT - Lituania 10
EG - Egitto 9
ID - Indonesia 9
SC - Seychelles 9
TT - Trinidad e Tobago 9
HN - Honduras 8
SV - El Salvador 8
VE - Venezuela 8
AU - Australia 7
KE - Kenya 7
MY - Malesia 7
PR - Porto Rico 7
AZ - Azerbaigian 6
CH - Svizzera 6
CL - Cile 6
KZ - Kazakistan 6
DO - Repubblica Dominicana 5
GR - Grecia 5
HR - Croazia 5
NI - Nicaragua 5
OM - Oman 5
PA - Panama 5
TH - Thailandia 5
TN - Tunisia 5
AM - Armenia 4
BB - Barbados 4
CI - Costa d'Avorio 4
DZ - Algeria 4
GE - Georgia 4
GP - Guadalupe 4
GT - Guatemala 4
HU - Ungheria 4
LB - Libano 4
NG - Nigeria 4
PY - Paraguay 4
RS - Serbia 4
SN - Senegal 4
UY - Uruguay 4
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
CW - ???statistics.table.value.countryCode.CW??? 3
KW - Kuwait 3
LV - Lettonia 3
NO - Norvegia 3
PT - Portogallo 3
RO - Romania 3
EU - Europa 2
GD - Grenada 2
KH - Cambogia 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MD - Moldavia 2
MM - Myanmar 2
MN - Mongolia 2
Totale 132.019
Salva come PNG Salva come JPEG
Città #
Cagliari 114.306
Uta 3.221
Ashburn 890
Singapore 604
Fairfield 589
San Jose 494
Dallas 424
Woodbridge 416
Chandler 361
Houston 312
Ann Arbor 279
Boardman 263
Nyköping 255
Seattle 248
Wilmington 208
Beijing 200
Council Bluffs 195
Cambridge 186
Los Angeles 171
Jacksonville 156
New York 145
Santa Clara 136
Dearborn 127
Helsinki 119
Shanghai 113
Hefei 87
Ho Chi Minh City 83
Hong Kong 81
Boston 76
The Dalles 75
Lauterbourg 71
Seoul 68
Hanoi 67
Munich 62
Nanjing 61
Rome 51
Dong Ket 45
Milan 45
Buffalo 41
Orem 40
Frankfurt am Main 39
San Diego 36
Chennai 35
Denver 35
Shenyang 34
Columbus 33
Phoenix 33
São Paulo 33
Washington 33
Atlanta 32
Chicago 31
Toronto 31
Redwood City 29
Turku 29
Montreal 28
Brooklyn 27
London 27
Amsterdam 26
Tokyo 26
Kocaeli 24
Madrid 23
Guangzhou 21
Redondo Beach 21
Warsaw 21
Manchester 19
Mountain View 19
Tashkent 19
Princeton 18
San Francisco 18
Tianjin 17
Nuremberg 16
Poplar 16
Verona 16
Baghdad 15
Sassari 15
Tucson 15
Wuhan 15
Baltimore 14
Stockholm 14
Arlington 13
Brussels 13
Dublin 13
Düsseldorf 13
Hebei 13
Jiaxing 13
Rio de Janeiro 13
Vienna 13
Da Nang 12
Lappeenranta 12
Mexico City 12
Miami 12
Amman 11
Brasília 11
Casablanca 11
Changsha 11
Johannesburg 11
Las Vegas 11
Newark 11
Addis Ababa 10
City of London 10
Totale 126.573
Salva come PNG Salva come JPEG
Nome #
Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study 6.693
Δ9-Tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity 3.926
Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives 3.425
Adolescent Δ 9-Tetrahydrocannabinol exposure alters WIN55,212-2 self-administration in adult rats 3.410
Cannabinoid CB1/CB2 receptor agonists attenuate hyperactivity and body weight loss in a rat model of activity-based anorexia 3.359
Emotional profile of female rats showing binge eating behavior 3.280
Limited access to a high fat diet alters endocannabinoid tone in female rats 3.119
Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms 2.993
The Role of the Endocannabinoid System in Eating Disorders: Neurochemical and Behavioural Preclinical Evidence. 2.977
Cannabinoid Modulation of Eukaryotic Initiation Factors (eIF2α and eIF2B1) and Behavioral Cross-Sensitization to Cocaine in Adolescent Rats 2.927
Behavioural and neurochemical assessment of salvinorin A abuse potential in the rat 2.896
Adolescent THC exposure and vulnerability to drug abuse: Sex differences 2.864
Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward 2.843
New perspectives on the use of cannabis in the treatment of psychiatric disorders 2.739
Impaired brain endocannabinoid tone in the activity-based model of anorexia nervosa 2.622
The longitudinal trajectory of serum brain-derived neurotrophic factor (BDNF) levels in psychotic patients: a prospective observational study 2.615
BDNF serum levels as a biomarker of depressive symptoms in psychotic disorders 2.533
Pharmacological modulation of the endocannabinoid signalling alters binge-type eating behaviour in female rats. 2.490
Gene knockout animal models of depression, anxiety and obsessive compulsive disorders 2.423
The endocannabinoid system: Anorexia nervosa and binge eating disorder 2.415
The impact of depot and long acting injectable antipsychotics on serum levels of brain-derived neurotrophic factor in schizophrenic and schizoaffective patients: results of a 24-month longitudinal prospective study 2.399
Brain activity of anandamide: a rewarding bliss? 2.296
Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors 2.258
CB2 antagonist AM630, monoacylglycerol lipase inhibitor JZL184 and cannabidiol did not affect hedonic properties of food in rats with binge eating behavior 2.248
Animal Models of Eating Disorders 2.181
Δ9-Tetrahydrocannabinol During Adolescence Attenuates Disruption of Dopamine Function Induced in Rats by Maternal Immune Activation 2.041
Alpha-Synuclein transgenic mice, h-α-SynL62, display α-Syn aggregation and a dopaminergic phenotype reminiscent of Parkinson's disease 1.972
Cannabinoid exposure in rat adolescence reprograms the initial behavioral, molecular, and epigenetic response to cocaine 1.919
Adolescent cannabinoid exposure induces irritability-like behavior and cocaine cross-sensitization without affecting the escalation of cocaine self-administration in adulthood 1.887
Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid 1.820
Evaluation of behavioral phenotypes in rats showing binge eating behavior 1.782
Altered brain levels of arachidonic acid-derived inflammatory eicosanoids in a rodent model of anorexia nervosa 1.706
AM404 attenuates reinstatement of nicotine seeking induced by nicotine-associated cues and nicotine priming but does not affect nicotine- and food-taking 1.663
Epigenetic regulation of the cannabinoid receptor CB1 in an activity-based rat model of anorexia nervosa 1.535
Conditioned place preference (CPP) in rats: From conditioning to reinstatement test 1.518
The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine-induced dopamine elevations in the nucleus accumbens shell in rats. 1.476
Rimonabant reduces fat intake in a behavioural model of binge-type eating 1.467
Baclofen prevents drug-induced reinstatement of extinguished nicotine-seeking behaviour and nicotine place preference in rodents 1.389
Self-administration of the anandamide transport inhibitor AM404 by squirrel monkeys 1.346
Cannabinoids and their therapeutic applications in mental disorders 1.305
Exploring the association between brain-derived neurotrophic factor levels and longitudinal psychopathological and cognitive changes in Sardinian psychotic patients 1.296
The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition 1.200
Dopamine and serotonin release in dorsal striatum and nucleus accumbens is differentially modulated by morphine in DBA/2J and C57BL/6J mice 1.184
Modeling Parkinson’s disease neuropathology and symptoms by intranigral inoculation of preformed human α-synuclein oligomers 1.173
Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats 1.154
The endocannabinoid system: a new molecular target for the treatment of tobacco addiction 1.098
K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research 1.096
Cannabinoid-opioid interaction in relapse to drug-seeking 1.090
The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate Cortex 1.064
Repeated exposure to JWH-018 induces adaptive changes in the mesolimbic and mesocortical dopamine pathways, glial cells alteration and behavioural correlates 1.058
Endocannabinoid system and opioid addiction: behavioural aspects 1.032
Fatty acid amide hydrolase (FAAH) inhibition enhances memory acquisition through activation of PPAR-alpha nuclear receptors. 982
Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat 980
Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3′-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats (Journal of Pharmacology and Experimental Therapeutics (2008) 327, (482-490)) (Erratum) 965
Changed accumbal responsiveness to alcohol in rats pre-treated with nicotine or the cannabinoid receptor agonist WIN 55,212-2 886
Effect of cannabinoids on reinstatement of morphine conditioned place preference (CPP) in mice 879
Nicotinic α7 receptors as a new target for treatment of cannabis abuse 859
Identifying Neurobiological Markers in Obsessive–Compulsive Disorder: A Study Protocol for a Cross-Sectional Study in Subgroups of Differing Phenotype 851
Converging Evidence Points to BDNF as Biomarker of Depressive Symptoms in Schizophrenia-Spectrum Disorders 799
Effect of Baclofen on Nicotine, Cocaine and Morphine-induced dopamine release in the shell portion of the nucleus accumbens of rat 793
The CB1 receptor antagonist AM251 blocks drug-induced reinstatement of nicotine conditioned place preference in rats 792
Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat 773
CB1 agonist administration modify 5-HT release in the nucleus accumbens and striatum of freely moving rats 754
Nicotinic facilitation of delta-9-tetrahydrocannabinol discrimination involves endogenous anandamide 753
null 738
null 711
Involvement of the 5-HT1a serotonergic receptors in the anxiety-like effects induced by the CB1 cannabinoid receptor agonist WIN 55,212-2 694
Cannabinoid mechanism in relapse to Heroin after extended abstinence in rats 605
Maternal immune activation impairs endocannabinoid signaling in the mesolimbic system of adolescent male offspring 596
Fluctations of extracellular dopamine levels in the shell portion of the rat nucleus accumbens during cannabinoid self-administration 579
An overall view of the most common experimental models for multiple sclerosis 578
Effect of cannabinoid CB1 receptor agonist WIN 55,212-2 in the elevated plus maze test: role of the serotonergic system 567
Induction of Activity-Regulated Cytoskeleton-Associated Protein and c-Fos Expression in an Animal Model of Anorexia Nervosa 561
Symptomatic remission and recovery in major psychosis: Is there a role for BDNF? A secondary analysis of the LABSP cohort data 507
Anaplastic Lymphoma Kinase Receptor: Possible Involvement in Anorexia Nervosa 475
Modeling Anorexia Nervosa 428
A Secondary Analysis of the Complex Interplay between Psychopathology, Cognitive Functions, Brain Derived Neurotrophic Factor Levels, and Suicide in Psychotic Disorders: Data from a 2-Year Longitudinal Study 413
The Role of Lysophosphatidic Acid in Neuropsychiatric and Neurodegenerative Disorders 381
Cannabinoids and reward: Interactions with the opioid system 342
Activity-based anorexia (ABA) model: Effects on brain neuroinflammation, redox balance and neuroplasticity during the acute phase 332
Cannabinoid self-administration increases dopamine release in the nucleus accumbens 303
Do Long-Acting Injectable Antipsychotics Influence Serum Levels of Brain-Derived Neurotrophic Factor in People with Schizophrenia and Schizoaffective Disorder? 286
Food restriction and hyperactivity induce changes in corticolimbic brain dopamine and serotonin levels in female rats 242
Impact of repetitive transcranial magnetic stimulation on clinical and cognitive outcomes, and brain-derived neurotrophic factor levels in treatment-resistant depression 199
Synaptoproteomic Analysis of the Prefrontal Cortex Reveals Spatio-Temporal Changes in SYNGAP1 Following Cannabinoid Exposure in Rat Adolescence 194
Antibody conjugates in neuroblastoma: a step forward in precision medicine 178
The clock is ticking on schizophrenia: a study protocol for a translational study integrating phenotypic, genomic, microbiome and biomolecular data to overcome disability 150
Cannabinoid-nicotine interactions 48
Food restriction and hyperactivity differentially shape microglial Iba1 immunoreactivity across feeding-, cognitive-, and reward-related circuits in the activity-based anorexia model 8
Totale 132.383
Salva come PNG Salva come JPEG
Categoria #
all - tutte 172.636
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 172.636
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225.098 0 0 0 0 847 523 355 327 678 873 880 615
2022/202311.489 792 1.339 1.631 923 891 1.188 695 923 805 803 1.015 484
2023/202411.092 518 379 465 692 1.162 1.916 1.828 726 615 808 937 1.046
2024/202522.262 5.683 5.870 2.906 2.449 1.151 1.358 1.625 156 285 215 249 315
2025/20267.204 749 510 777 635 551 531 979 306 482 899 465 320
2026/20272.108 241 466 456 786 159 0 0 0 0 0 0 0
Totale 132.383